Analysis of candidate genes at the IBGC1 locus associated with idiopathic basal ganglia calcification ("Fahr's disease")

Journal of Molecular Neuroscience

Volumn 33, Issue 2, 2007, Pages 151-154

  Oliveira, J R M ^a,b   Sobrido, M J ^a   Spiteri, E ^a   Hopfer, S ^a   Meroni, G ^c   Petek, E ^d   Baquero, M ^e   Geschwind, D H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^c CNR   (Italy)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Basal ganglia calcification; Fahr's disease; Neuropsychiatric disorders; Parkinsonism; Sequencing

Indexed keywords

ARTICLE; BASAL GANGLION; BRAIN REGION; CHROMOSOME 14Q; EXON; FAHR DISEASE; FAMILIAL DISEASE; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC SCREENING; GENETIC VARIABILITY; HETEROZYGOSITY; HUMAN; MASS SCREENING; MENTAL DISEASE; NEUROIMAGING; NEUROLOGIC DISEASE; PARKINSONISM; SINGLE NUCLEOTIDE POLYMORPHISM;

BASAL GANGLIA DISEASES; CALCINOSIS; DNA MUTATIONAL ANALYSIS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE (GENETICS); MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 35348855691     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-007-0030-7     Document Type: Article

References (21)

1. Brodaty, H., Mitchell, P., Luscombe, G., Kwok, J. J., Badenhop, R. F., McKenzie, R., et al. (2002). Familial idiopathic basal ganglia calcification (Fahr's disease) without neurological, cognitive and psychiatric symptoms is not linked to the IBGC1 locus on chromosome 14q. Human Genetics, 110, 8-14.
2. Comtesse, N., Niedermayer, I., Glass, B., Heckel, D., Maldener, E., Nastainczyk, W., et al. (2002). MGEA6 is tumor-specific overexpressed and frequently recognized by patient-serum antibodies. Oncogene, 21, 239-247.
3. Comtesse, N., Reus, K., & Meese, E. (2001). The MGEA6 Multigene family has the active locus on 14q and least nine psudogenes on different chromosomes. Genomics, 75(1-3), 1-6.
4. Freudenberg-Hua, Y., Freudenberg, J., Kluck, N., Cichon, S., Propping, P., & Nothen, M. M. (2003). Single nucleotide variation analysis in 65 candidate genes for CNS disorders in a representative sample of the European population. Genome Research, 13(10), 2271-2276.
5. Fujita, D., Terada, S., Ishizu, H., Yokota, O., Nakashima, H., Ishihara, T., et al. (2003). Immunohistochemical examination on intracranial calcification in neurodegenerative diseases. Acta Neuropathologica, 105, 259-264.
6. Geschwind, D. H., Loginov, M., & Stern, J. M. (1999). Identification of a locus on chromosome 14q for idiopathic basal ganglia calcification (Fahr disease). American Journal of Human Genetics, 65, 764-772.
7. Lhatoo, S. D., Perunovic, B., Love, S., Houlden, H., & Campbell, M. J. (2003). Familial idiopathic brain calcification - A new and familial alpha-synucleinopathy? European Neurology, 49, 223-226.
8. Macias, M. J., Hyvonen, M., Baraldi, E., Schultz, J., Sudol, M., Saraste, M., et al. (1996). Structure of the WW domain of a kinase-associated protein complexed with a proline-rich peptide. Nature, 382, 646-649.
9. Macias, M. J., Wiesner, S., & Sudol, M. (2002). WW and SH3 domains, two different scaffolds to recognize proline-rich ligands. FEBS Letters, 513, 30-37.
10. Manyam, B. V. (2005). What is and what is not 'Fahr's disease'. Parkinsonism & Related Disorders, 11(2), 73-80.
11. Morita, M., Tsuge, I., Matsuoka, H., Ito, Y., Itosu, T., Yamamoto, M., et al. (1998). Calcification in the basal ganglia with chronic active Epstein-Barr virus infection. Neurology, 50, 1485-1488.
12. Oliveira, J., Sobrido, M. J., Hopfer, S., Spiteri, E., Klepper, J., Gilbert, J., et al. (2004). Genetic heterogeneity in Familial Idiopathic basal Ganglia Calcification ("Fahr's disease"). Neurology, 63, 2165-2167.
13. Rozen, S., & Skaletsky, H. (2000). Primer3 on the WWW for general users and for biologist programmers. Methods in Molecular Biology, 132, 365-386.
14. Sansom, M. S. P., & Weinstein, H. (2000). Hinges, swivels and switches: the role of pralines in signaling via transmembrane α-helices. TiPS, 21, 445-451.
15. Schmidt, U., Mursch, K., & Halatsch, M. E. (2005). Symmetrical intracerebral and intracerebellar calcification ("Fahr's disease"). Functional Neurology, 20(1), 15.
16. Schwarzbraun, T., Vincet, J. B., Schumacher, A., Geschwind, D. H., Oliveira, J., Windpassinger, C., et al. (2004). Cloning of TULIP1, a novel CpG island associated, brain expressed candidate gene for 14q13-linked neurological phenotypes and its murine homologue. Genomics, 84(3), 577-586.
17. Shakibai, S. V., Johnson, J. P., & Bourgeois, J. A. (2005). Paranoid delusions and cognitive impairment suggesting Fahr's disease. Psychosomatics, 46(6), 569-572.
18. Sobrido, M. J., & Geschwind, D. H. (2002). Genetics of familial idiopathic basal ganglia calcification (FIBGC). In S.-M. Pulst (Ed.), Genetics of movement disorders (pp. 443-448). San Diego: Academic Press.
19. Sobrido, M. J., Hopfer, S., & Geschwind, D. H. (2002). Idiopathic basal ganglia calcification. GeneReviews: Genetic Disease Online Reviews. www.geneclinics.org.
20. Sudol, M., Krzystof, S., & Russo, T. (2001). Functions of WW domains in the nucleus. FEBS Letters, 490, 190-195.
21. Usener, D., Schadendorf, D., Kock, J., Dubel, S., & Eichmuller, S. (2003). cTAGE: A cutaneous T Cell Lymphoma associated antigen family with tumor specific splicing. The Journal of Investigative Dermatology, 121, 198-206.